194 related articles for article (PubMed ID: 36007855)
1. Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress.
Zhang M; Hu M; Alles SRA; Montera MA; Adams I; Santi MD; Inoue K; Tu NH; Westlund KN; Ye Y
Neuropharmacology; 2022 Nov; 218():109233. PubMed ID: 36007855
[TBL] [Abstract][Full Text] [Related]
2. Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain.
Westlund KN; Zhang M
Molecules; 2020 Mar; 25(5):. PubMed ID: 32138198
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress.
Khasabova IA; Khasabov SG; Olson JK; Uhelski ML; Kim AH; Albino-Ramírez AM; Wagner CL; Seybold VS; Simone DA
Pain; 2019 Mar; 160(3):688-701. PubMed ID: 30507781
[TBL] [Abstract][Full Text] [Related]
4. The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPARγ Receptors.
Silva NR; Gomes FIF; Lopes AHP; Cortez IL; Dos Santos JC; Silva CEA; Mechoulam R; Gomes FV; Cunha TM; Guimarães FS
Neurotherapeutics; 2022 Jan; 19(1):434-449. PubMed ID: 34904193
[TBL] [Abstract][Full Text] [Related]
5. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain.
Toyama S; Shimoyama N; Shimoyama M
Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
Zanardelli M; Micheli L; Cinci L; Failli P; Ghelardini C; Di Cesare Mannelli L
PLoS One; 2014; 9(7):e102758. PubMed ID: 25036594
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies.
Furgała-Wojas A; Kowalska M; Nowaczyk A; Fijałkowski Ł; Sałat K
Curr Drug Metab; 2020; 21(7):548-561. PubMed ID: 32651960
[TBL] [Abstract][Full Text] [Related]
8. Phytochemicals of Cinnamomi Cortex: Cinnamic Acid, but not Cinnamaldehyde, Attenuates Oxaliplatin-Induced Cold and Mechanical Hypersensitivity in Rats.
Chae HK; Kim W; Kim SK
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30791474
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
Churi SB; Abdel-Aleem OS; Tumber KK; Scuderi-Porter H; Taylor BK
J Pain; 2008 Jul; 9(7):639-49. PubMed ID: 18387855
[TBL] [Abstract][Full Text] [Related]
10. TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy.
Marcotti A; Fernández-Trillo J; González A; Vizcaíno-Escoto M; Ros-Arlanzón P; Romero L; Vela JM; Gomis A; Viana F; de la Peña E
Brain; 2023 Feb; 146(2):475-491. PubMed ID: 35871491
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
12. Pharmacopuncture With Scolopendra subspinipes Suppresses Mechanical Allodynia in Oxaliplatin-Induced Neuropathic Mice and Potentiates Clonidine-induced Anti-allodynia Without Hypotension or Motor Impairment.
Yoon SY; Lee JY; Roh DH; Oh SB
J Pain; 2018 Oct; 19(10):1157-1168. PubMed ID: 29758357
[TBL] [Abstract][Full Text] [Related]
13. TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain.
Aloi VD; Pinto SJPC; Van Bree R; Luyten K; Voets T; Vriens J
Pain; 2023 Sep; 164(9):2060-2069. PubMed ID: 37079852
[TBL] [Abstract][Full Text] [Related]
14. Anti-allodynic and anti-inflammatory effects of 17α-hydroxyprogesterone caproate in oxaliplatin-induced peripheral neuropathy.
Miguel CA; Raggio MC; Villar MJ; Gonzalez SL; Coronel MF
J Peripher Nerv Syst; 2019 Mar; 24(1):100-110. PubMed ID: 30680838
[TBL] [Abstract][Full Text] [Related]
15. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
[TBL] [Abstract][Full Text] [Related]
16. Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice.
Sałat K; Furgała A; Sałat R
Biomed Pharmacother; 2019 Mar; 111():882-890. PubMed ID: 30841467
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for pain: reversing inflammatory and neuropathic pain with the anticancer agent mithramycin A.
Xu Z; Lee MC; Sheehan K; Fujii K; Rabl K; Rader G; Varney S; Sharma M; Eilers H; Kober K; Miaskowski C; Levine JD; Schumacher MA
Pain; 2024 Jan; 165(1):54-74. PubMed ID: 37366593
[TBL] [Abstract][Full Text] [Related]
18. PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway.
Zhou YQ; Liu DQ; Chen SP; Chen N; Sun J; Wang XM; Li DY; Tian YK; Ye DW
Biomed Pharmacother; 2020 Sep; 129():110356. PubMed ID: 32535388
[TBL] [Abstract][Full Text] [Related]
19. PPARγ activation blocks development and reduces established neuropathic pain in rats.
Morgenweck J; Griggs RB; Donahue RR; Zadina JE; Taylor BK
Neuropharmacology; 2013 Jul; 70():236-46. PubMed ID: 23415633
[TBL] [Abstract][Full Text] [Related]
20. αO-Conotoxin GeXIVA[1,2] Reduced Neuropathic Pain and Changed Gene Expression in Chronic Oxaliplatin-Induced Neuropathy Mice Model.
Wang H; Li X; Qiao Y; Wang M; Wang W; McIntosh JM; Zhangsun D; Luo S
Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38276651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
